General discussion 157 75 Bruneau, M. et al. Long-term follow-up survey reveals a high yield, up to 30% of patients presenting newly detected aneurysms more than 10 years after ruptured intracranial aneurysms clipping. Neurosurg Rev 34, 485-496, (2011). 76 Wermer, M. J. et al. Follow-up screening after subarachnoid haemorrhage: frequency and determinants of new aneurysms and enlargement of existing aneurysms. Brain 128, 2421-2429, (2005). 77 Roy, D., Milot, G. & Raymond, J. Endovascular treatment of unruptured aneurysms. Stroke 32, 1998-2004, (2001). 78 Ferns, S. P. et al. Coiling of intracranial aneurysms: a systematic review on initial occlusion and reopening and retreatment rates. Stroke 40, e523-529, (2009). 79 Tailor, J. et al. Stability of ruptured intracranial aneurysms treated with detachable coils: is delayed follow-up angiography warranted? Br J Neurosurg 24, 405-409, (2010). 80 Bala, M. V. & Mauskopf, J. A. Optimal assignment of treatments to health states using a Markov decision model: an introduction to basic concepts. Pharmacoeconomics 24, 345-354, (2006). 81 Briggs, A. & Sculpher, M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 13, 397-409, (1998). 82 Sonnenberg, F. A. & Beck, J. R. Markov models in medical decision making: a practical guide. Med Decis Making 13, 322-338, (1993). 83 Schaafsma, J. D. et al. Cost-effectiveness of magnetic resonance angiography versus intra-arterial digital subtraction angiography to follow-up patients with coiled intracranial aneurysms. Stroke 41, 1736-1742, (2010). 84 Wermer, M. J., Buskens, E., van der Schaaf, I. C., Bossuyt, P. M. & Rinkel, G. J. Yield of screening for new aneurysms after treatment for subarachnoid hemorrhage. Neurology 62, 369-375, (2004). 85 Wermer, M. J., Koffijberg, H. & van der Schaaf, I. C. Effectiveness and costs of screening for aneurysms every 5 years after subarachnoid hemorrhage. Neurology 70, 2053-2062, (2008). 86 Schaafsma, J. D., van der Graaf, Y., Rinkel, G. J. & Buskens, E. Decision analysis to complete diagnostic research by closing the gap between test characteristics and cost-effectiveness. J Clin Epidemiol 62, 1248- 1252, (2009). 87 Van den Bruel, A., Cleemput, I., Aertgeerts, B., Ramaekers, D. & Buntinx, F. The evaluation of diagnostic tests: evidence on technical and diagnostic accuracy, impact on patient outcome and cost-effectiveness is needed. J Clin Epidemiol 60, 1116-1122, (2007). 88 Bossuyt, P. M. et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. AJR Am J Roentgenol 181, 51-55, (2003).
proefschrit Van Zwam inhoud met kaft en stellingen.indd
To see the actual publication please follow the link above